CCR5 and neoplasm: Notably, when cells derived from tumours harvested from MMTV-PyMT.CCR5−/− mice (described in Material and methods) are treated with CCL5, we observe no enhancement in glucose uptake, in support that CCR5 is the receptor mediating this effect (figure 2d).